Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 215-225 , February 2010

A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog

Received 8 December 2008 ,Revised 1 April 2009 ,Accepted 11 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0306-4530(09)00197-8

doi: 10.1016/j.psyneuen.2009.06.012

Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 215-225 , February 2010